The Predictive Role of Hepatitis B Biomarkers on HBV Reactivation following Direct-Acting Antiviral Therapy in HBV/HCV Coinfected Patients

Hepatitis B and C (HBV/HCV) coinfected patients have a potential risk of hepatitis B reactivation (HBVr) after direct-acting antivirals (DAAs) treatment. The study intends to investigate the predictive role of HBV biomarkers in HBVr. Forty-six HBV/HCV coinfected patients receiving DAAs were enrolled...

Full description

Bibliographic Details

Published in:	Viruses
Main Authors:	Chih-Wei Tseng, Wen-Chun Liu, Ping-Hung Ko, Yen-Chun Chen, Kuo-Chih Tseng, Ting-Tsung Chang
Format:	Article
Language:	English
Published:	MDPI AG 2022-08-01
Subjects:	hepatitis B surface antigen hepatitis B core-related antigen HBV pregenomic RNA hepatitis C HBV/HCV coinfection direct-acting antiviral
Online Access:	https://www.mdpi.com/1999-4915/14/8/1812